"The spirit of partnership in this joint venture has all been about channelling the core strengths of both Zydus and Bayer for the benefit ...

"More clarity on the proposed structure, valuations can be expected in the next six months," a source said adding that the merger may or ma...

In terms of valuations, the gap between the top league and midcap pharma companies like Cadila Healthcare is not much now, says Jani.

Zydus BSV Pharma, founded in 2005, is a joint venture (JV) company of Cadila Healthcare and biotech firm Bharat Serums and Vaccines (BSV).

Ahmedabad-based drug company, is looking for setting up a SPV for funding innovation done by individual or start-up firms in the field of d...

We think that this is one space which gives a comfort in terms of their earnings quality and the margins continue to look good, says Jani.

In 2007, Zydus had picked up 100% stake in Nippon Universal Pharmaceutical Ltd. Cadila had said it will give critical access to ready manuf...

Described as the most important innovation in the discovery of antibiotics since Alexander Fleming's original breakthrough more than 80 yea...

The company is looking for an opportunity in Astrakhan to acquire land for setting up manufacturing unit in that country.

CLSA is of the view that this will continue to fuel strong demand for pharmaceuticals especially for lifestyle related therapy segments.

Founder of Ahmedabad-based Cadila Pharmaceuticals, Indravadan Modi, better known as the octogenarian horse-riding chairman, passed away at ...

Cadila's second Indian facility outside Gujarat will come up at Rajasthan. The bulk drug facility will be set up near Udaipur with an initi...

Shares of Sun Pharma and Cadila healthcare came down sharply, as the Finance Minister increased the scope of Minimum Alternative Tax (MAT) ...

Bactiguard provides solutions preventing hospital acquired infections, which are the fourth largest cause of death in the western world.

"960 is a very strong resistance downside, 910-920 is a very strong support. So whatever the news is, I do not see a crackdown in Cadila. "

Ahmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...

Ahmedabad-based Rs 800-crore Cadila Pharmaceuticals Ltd is all geared up for a large pie in the $665-million vaccine market in India.